Parkside Financial Bank & Trust’s Vaxcyte PCVX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.1K	Hold	105	–	–	﹤0.01%	1757
2025 Q4	$4.84K	Buy	105 +14	+15%	+$626	﹤0.01%	1811
2025 Q3	$3.28K	Buy	91 +20	+28%	+$663	﹤0.01%	1858
2025 Q2	$2.31K	Buy	71 +66	+1,320%	+$2.16K	﹤0.01%	1955
2025 Q1	$189	Buy	+5	New	+$400	﹤0.01%	2684

Other funds holding PCVX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parkside Financial Bank & Trust's PCVX Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Vaxcyte (PCVX) position steady in Q1 2026 at 105 shares worth $6.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

Parkside Financial Bank & Trust first reported a position in PCVX in Q1 2025 and has held it in 5 quarters since. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

Parkside Financial Bank & Trust held 105 shares of Vaxcyte worth $6.1K as of Q1 2026.
Parkside Financial Bank & Trust left its Vaxcyte share count unchanged in Q1 2026.
Vaxcyte made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1757 holding.
Parkside Financial Bank & Trust first reported a position in Vaxcyte in Q1 2025 and has held it in 5 quarters since.
336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.